Tenet Healthcare Dirección
Dirección controles de criterios 2/4
El CEO de Tenet Healthcare es Saum Sutaria , nombrado en Sep 2021, tiene una permanencia de 3.17 años. compensación anual total es $18.52M, compuesta por 8.1% salario y 91.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.29% de las acciones de la empresa, por valor de $41.64M. La antigüedad media del equipo directivo y de la junta directiva es de 3.7 años y 6.5 años, respectivamente.
Información clave
Saum Sutaria
Chief Executive Officer (CEO)
US$18.5m
Compensación total
| Porcentaje del salario del CEO | 8.1% |
| Permanencia del CEO | 3.2yrs |
| Participación del CEO | 0.3% |
| Permanencia media de la dirección | 3.7yrs |
| Promedio de permanencia en la Junta Directiva | 6.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Nov 17
Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services
Nov 04With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
Oct 30Tenet Healthcare: Becoming A Very Healthy Business
Sep 09Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price
Sep 06Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)
Aug 29Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Aug 13An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued
Jul 11Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)
Jun 17With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
May 21Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit
Apr 30Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?
Mar 18Tenet Healthcare: Shrinking To Grow
Feb 04Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks
Dec 18We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt
Nov 15Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt
Oct 13Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?
Aug 02Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now
Jul 28Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?
Apr 13USPI and Providence extend hands to aid ambulatory surgical services
Feb 09Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$19m | US$2m | US$611m |
| Sep 30 2023 | n/a | n/a | US$469m |
| Jun 30 2023 | n/a | n/a | US$499m |
| Mar 31 2023 | n/a | n/a | US$414m |
| Dec 31 2022 | US$11m | US$1m | US$410m |
| Sep 30 2022 | n/a | n/a | US$558m |
| Jun 30 2022 | n/a | n/a | US$875m |
| Mar 31 2022 | n/a | n/a | US$957m |
| Dec 31 2021 | US$21m | US$1m | US$915m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$434m |
| Mar 31 2021 | n/a | n/a | US$402m |
| Dec 31 2020 | US$9m | US$1m | US$399m |
| Sep 30 2020 | n/a | n/a | -US$18m |
| Jun 30 2020 | n/a | n/a | -US$48m |
| Mar 31 2020 | n/a | n/a | -US$112m |
| Dec 31 2019 | US$14m | US$962k | -US$226m |
Compensación vs. Mercado: La compensación total de Saum($USD18.52M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD12.73M).
Compensación vs. Ingresos: La compensación de Saum ha aumentado más de un 20% en el último año.
CEO
Saum Sutaria (51 yo)
3.2yrs
Permanencia
US$18,518,110
Compensación
Dr. Saumya Sutaria, M.D., also known as Saum, serves as Member of Advisory Board at Vida Health, Inc. Dr. Sutaria served as Chief Operating Officer at Tenet Healthcare Corp. since January 06, 2019 until S...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & CEO | 3.2yrs | US$18.52m | 0.29% $ 41.6m | |
| Executive VP & Chief Information Officer | 6.5yrs | US$2.47m | 0.023% $ 3.3m | |
| EVP, Chief Administrative Officer | 3.7yrs | US$3.67m | sin datos | |
| Executive Vice President of Commercial Operations | 2.7yrs | US$3.24m | 0.016% $ 2.4m | |
| Executive VP & CFO | less than a year | sin datos | sin datos | |
| Vice President of Investor Relations | no data | sin datos | sin datos | |
| Senior VP & Chief Compliance Officer | no data | sin datos | sin datos | |
| Executive Vice President of Corporate Development | 7.8yrs | sin datos | sin datos | |
| Chief Managed Care Officer & Senior VP | 17.3yrs | sin datos | sin datos | |
| Chief Applied Clinical Informatics Officer | no data | sin datos | sin datos | |
| Chief Administrative Officer - USPI | 1.8yrs | sin datos | sin datos | |
| Senior Vice President & Chief Clinical Operations Officer | 5.8yrs | sin datos | sin datos |
3.7yrs
Permanencia media
55yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de THC se considera experimentado (3.7 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & CEO | 4yrs | US$18.52m | 0.29% $ 41.6m | |
| Independent Director | 7.1yrs | US$333.54k | 0.040% $ 5.8m | |
| Independent Director | 1.5yrs | US$238.93k | 0% $ 0 | |
| Independent Director | 6.5yrs | US$339.04k | 0.0081% $ 1.2m | |
| Lead Independent Director | 23.7yrs | US$541.53k | 0.024% $ 3.5m | |
| Independent Director | 7yrs | US$335.04k | 0.018% $ 2.6m | |
| Independent Director | 7yrs | US$351.04k | 0.0070% $ 1.0m | |
| Independent Director | 9.7yrs | US$356.04k | 0.051% $ 7.4m | |
| Independent Director | 5.3yrs | US$331.04k | 0.00029% $ 42.3k | |
| Executive Chairman of Aspen Healthcare | no data | sin datos | sin datos | |
| Independent Director | 3.8yrs | US$327.04k | 0.0018% $ 258.1k | |
| Independent Director | 5.1yrs | US$320.04k | 0.021% $ 3.0m |
6.5yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de THC se considera experimentada (6.5 años de antigüedad promedio).